Astec LifeSciences Limited (BOM:533138)

Astec LifeSciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16,502	13,243	20,932	27,154	34,391	19,653
Market Cap Growth	21.91%	-36.73%	-22.91%	-21.04%	74.99%	158.64%
Enterprise Value	20,078	18,229	25,222	29,616	36,253	20,638
Last Close Price	740.40	669.91	1054.36	1370.87	1736.51	990.11
PE Ratio	-	-	-	106.22	38.27	30.21
PS Ratio	4.03	3.47	4.56	4.32	5.08	3.52
PB Ratio	3.98	5.64	5.67	6.47	8.67	6.35
P/TBV Ratio	4.24	6.27	5.98	6.73	8.93	6.46
P/OCF Ratio	-	-	204.79	36.37	145.70	-
EV/Sales Ratio	4.91	4.78	5.50	4.71	5.36	3.69
EV/EBITDA Ratio	-	-	-	39.00	23.60	18.02
EV/EBIT Ratio	-	-	-	68.15	30.13	23.00
Debt / Equity Ratio	0.89	2.36	1.34	0.81	0.70	0.61
Debt / EBITDA Ratio	-	-	-	4.47	1.81	1.63
Net Debt / Equity Ratio	0.86	2.36	1.34	0.81	0.70	0.60
Net Debt / EBITDA Ratio	-81.77	-8.27	-80.19	4.49	1.82	1.63
Net Debt / FCF Ratio	-	-18.33	-3.94	-8.00	-3.47	-1.69
Asset Turnover	-	0.41	0.47	0.67	0.86	0.89
Inventory Turnover	-	1.72	1.32	1.69	2.68	3.04
Quick Ratio	-	0.41	0.43	0.30	0.57	0.59
Current Ratio	-	0.93	1.00	0.95	1.05	1.02
Return on Equity (ROE)	-	-44.57%	-11.88%	6.27%	25.46%	23.40%
Return on Assets (ROA)	-	-7.40%	-2.66%	2.90%	9.55%	8.98%
Return on Invested Capital (ROIC)	-6.86%	-13.31%	-5.13%	4.43%	15.24%	15.58%
Return on Capital Employed (ROCE)	-	-21.30%	-7.20%	9.60%	29.60%	25.20%
Earnings Yield	-5.41%	-10.18%	-2.24%	0.94%	2.61%	3.31%
FCF Yield	-	-2.28%	-5.99%	-1.57%	-2.34%	-5.63%
Dividend Yield	-	-	0.14%	0.11%	0.09%	0.15%
Payout Ratio	-	-	-	11.50%	3.27%	4.51%
Buyback Yield / Dilution	-5.75%	-0.01%	-0.02%	-0.04%	-0.05%	-0.09%
Total Shareholder Return	-5.75%	-0.01%	0.13%	0.07%	0.04%	0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.